STKLD1
geneOn this page
Also known as MGC43306SGK071
Summary
STKLD1 (serine/threonine kinase like domain containing 1, HGNC:28669) is a protein-coding gene on chromosome 9q34.2, encoding Serine/threonine kinase-like domain-containing protein STKLD1 (Q8NE28).
Predicted to enable protein serine/threonine kinase activity.
Source: NCBI Gene 169436 — RefSeq curated summary.
At a glance
- Gene–disease (curated): polydactyly (Limited, GenCC)
- GWAS associations: 6
- Clinical variants (ClinVar): 125 total
- MANE Select transcript:
NM_153710
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28669 |
| Approved symbol | STKLD1 |
| Name | serine/threonine kinase like domain containing 1 |
| Location | 9q34.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC43306, SGK071 |
| Ensembl gene | ENSG00000198870 |
| Ensembl biotype | protein_coding |
| OMIM | 618530 |
| Entrez | 169436 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding_CDS_not_defined, 1 protein_coding
ENST00000371957, ENST00000462310, ENST00000468046, ENST00000475232, ENST00000477284
RefSeq mRNA: 1 — MANE Select: NM_153710
NM_153710
CCDS: CCDS35169
Canonical transcript exons
ENST00000371957 — 18 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001245901 | 133404789 | 133404929 |
| ENSE00001245908 | 133403920 | 133404048 |
| ENSE00001245915 | 133403700 | 133403828 |
| ENSE00001245922 | 133402878 | 133403012 |
| ENSE00001245932 | 133401738 | 133401878 |
| ENSE00001246026 | 133405252 | 133406096 |
| ENSE00001819237 | 133376366 | 133376560 |
| ENSE00003479402 | 133390681 | 133390796 |
| ENSE00003482661 | 133379036 | 133379122 |
| ENSE00003499410 | 133394291 | 133394409 |
| ENSE00003545799 | 133387447 | 133387548 |
| ENSE00003580620 | 133400413 | 133400529 |
| ENSE00003596074 | 133395600 | 133395763 |
| ENSE00003628970 | 133397972 | 133398055 |
| ENSE00003643948 | 133383856 | 133383900 |
| ENSE00003648357 | 133389526 | 133389596 |
| ENSE00003656479 | 133385617 | 133385691 |
| ENSE00003661814 | 133397164 | 133397294 |
Expression profiles
Bgee: expression breadth ubiquitous, 133 present calls, max score 87.46.
FANTOM5 (CAGE): breadth broad, TPM avg 0.3948 / max 25.0981, expressed in 185 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 99269 | 0.3659 | 174 |
| 99270 | 0.0289 | 4 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 87.46 | gold quality |
| left testis | UBERON:0004533 | 87.44 | gold quality |
| testis | UBERON:0000473 | 86.74 | gold quality |
| sural nerve | UBERON:0015488 | 85.39 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.96 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.25 | gold quality |
| right frontal lobe | UBERON:0002810 | 77.45 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 77.06 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 77.06 | gold quality |
| frontal cortex | UBERON:0001870 | 76.85 | gold quality |
| primary visual cortex | UBERON:0002436 | 76.83 | gold quality |
| prefrontal cortex | UBERON:0000451 | 76.69 | gold quality |
| cerebral cortex | UBERON:0000956 | 76.50 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 76.47 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 76.46 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 76.06 | gold quality |
| temporal lobe | UBERON:0001871 | 75.73 | gold quality |
| amygdala | UBERON:0001876 | 75.72 | gold quality |
| Ammon’s horn | UBERON:0001954 | 75.54 | gold quality |
| putamen | UBERON:0001874 | 74.48 | gold quality |
| substantia nigra | UBERON:0002038 | 74.29 | gold quality |
| brain | UBERON:0000955 | 74.23 | gold quality |
| nucleus accumbens | UBERON:0001882 | 74.15 | gold quality |
| cortical plate | UBERON:0005343 | 73.99 | gold quality |
| hypothalamus | UBERON:0001898 | 73.27 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 72.97 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 72.91 | gold quality |
| caudate nucleus | UBERON:0001873 | 72.86 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 72.72 | gold quality |
| cerebellar cortex | UBERON:0002129 | 72.71 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.86 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
42 targeting STKLD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-3714 | 99.71 | 70.74 | 2671 |
| HSA-MIR-4530 | 99.69 | 66.47 | 1509 |
| HSA-MIR-3158-5P | 99.65 | 67.51 | 1763 |
| HSA-MIR-6512-3P | 99.65 | 66.07 | 1468 |
| HSA-MIR-6720-5P | 99.65 | 66.22 | 1459 |
| HSA-MIR-762 | 99.58 | 66.61 | 1994 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-3136-3P | 99.57 | 66.59 | 781 |
| HSA-MIR-7155-3P | 99.57 | 66.48 | 794 |
| HSA-MIR-4498 | 99.47 | 67.42 | 2360 |
| HSA-MIR-940 | 99.37 | 66.14 | 2064 |
| HSA-MIR-584-3P | 99.35 | 67.69 | 1082 |
| HSA-MIR-6808-5P | 99.31 | 66.23 | 2150 |
| HSA-MIR-6893-5P | 99.31 | 66.25 | 2119 |
| HSA-MIR-6744-3P | 99.22 | 64.41 | 972 |
| HSA-MIR-4757-5P | 99.12 | 64.51 | 981 |
| HSA-MIR-4254 | 99.11 | 65.15 | 1315 |
| HSA-MIR-5001-5P | 99.05 | 66.76 | 1972 |
| HSA-MIR-4274 | 98.59 | 66.10 | 630 |
| HSA-MIR-193A-3P | 98.59 | 66.36 | 769 |
| HSA-MIR-193B-3P | 98.59 | 66.62 | 748 |
| HSA-MIR-1910-3P | 98.44 | 67.51 | 1695 |
| HSA-MIR-6511A-5P | 98.13 | 67.47 | 1770 |
Literature-anchored findings (GeneRIF, showing 1)
- Also known as SgK071, a unique kinase belonging to no group or family. Single orthologs have been found in other vertebrates and lower metazoans including Nematostella, but are absent from Drosophila and C. elegans. (PMID:12471243)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Stkld1 | ENSMUSG00000049897 |
| rattus_norvegicus | Stkld1 | ENSRNOG00000027911 |
Protein
Protein identifiers
Serine/threonine kinase-like domain-containing protein STKLD1 — Q8NE28 (reviewed: Q8NE28)
Alternative names: Serine/threonine kinase-like domain-containing protein 1, Sugen kinase 071
All UniProt accessions (1): Q8NE28
UniProt curated annotations — full annotation on UniProt →
Domain organisation. The protein kinase domain is predicted to be catalytically inactive.
Similarity. Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. STKL subfamily.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NE28-1 | 1 | yes |
| Q8NE28-2 | 2 | |
| Q8NE28-3 | 3 |
RefSeq proteins (1): NP_714921* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000719 | Prot_kinase_dom | Domain |
| IPR011009 | Kinase-like_dom_sf | Homologous_superfamily |
| IPR016024 | ARM-type_fold | Homologous_superfamily |
Pfam: PF00069
UniProt features (13 total): splice variant 4, sequence variant 3, region of interest 2, binding site 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NE28-F1 | 82.64 | 0.48 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (2): 34–42; 57
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 0 (showing top):
GO Biological Process (1): protein phosphorylation (GO:0006468)
GO Molecular Function (4): protein serine/threonine kinase activity (GO:0004674), ATP binding (GO:0005524), nucleotide binding (GO:0000166), protein kinase activity (GO:0004672)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| phosphorylation | 1 |
| protein modification process | 1 |
| protein kinase activity | 1 |
| adenyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| kinase activity | 1 |
| phosphotransferase activity, alcohol group as acceptor | 1 |
| catalytic activity, acting on a protein | 1 |
Protein interactions and networks
STRING
396 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| STKLD1 | PAN3 | Q58A45 | 517 |
| STKLD1 | PEAK1 | Q9H792 | 497 |
| STKLD1 | SBK2 | P0C263 | 479 |
| STKLD1 | PEAK3 | Q6ZS72 | 453 |
| STKLD1 | KIAA0825 | Q8IV33 | 429 |
| STKLD1 | FAM20A | Q96MK3 | 400 |
| STKLD1 | SELENOO | Q9BVL4 | 386 |
| STKLD1 | JAK1 | P23458 | 385 |
| STKLD1 | ZNF141 | Q15928 | 371 |
| STKLD1 | LMBR1 | Q8WVP7 | 370 |
| STKLD1 | OBP2B | Q9NPH6 | 370 |
| STKLD1 | SRPK3 | Q9UPE1 | 365 |
| STKLD1 | IQCE | Q6IPM2 | 351 |
| STKLD1 | MYBPHL | A2RUH7 | 349 |
| STKLD1 | CEP126 | Q9P2H0 | 348 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PSMC3 | PSMD9 | psi-mi:“MI:0914”(association) | 0.940 |
| PSMD12 | PSMD11 | psi-mi:“MI:0914”(association) | 0.730 |
| PSMC3 | PSMD12 | psi-mi:“MI:0914”(association) | 0.640 |
BioGRID (8): STKLD1 (Affinity Capture-MS), STKLD1 (Co-fractionation), STKLD1 (Co-fractionation), STKLD1 (Co-fractionation), STKLD1 (Affinity Capture-MS), STKLD1 (Affinity Capture-MS), STKLD1 (Affinity Capture-MS), STKLD1 (Affinity Capture-MS)
ESM2 similar proteins: A1IGU3, A1IGU4, A1IGU5, A5D8V7, A5PK16, A6QP29, A7E3N7, A8K8P3, A9CB34, B0KWR6, B5DFA1, D3ZI76, G3HQ82, O73770, P0C7M6, P41002, Q14129, Q14DK4, Q15051, Q3SYS7, Q3UK37, Q3UZY0, Q5SNV9, Q5SXM2, Q60953, Q60I26, Q60I27, Q69ZT1, Q6NUI2, Q8BP00, Q8BP86, Q8C1F5, Q8C2K1, Q8CJ00, Q8IV45, Q8NCU4, Q8NE28, Q8NEE8, Q8TE82, Q95KD7
Diamond homologs: A0A8I5ZNK2, D3ZBE5, G5ECN5, G5EEN4, G5EFU0, O23304, O76484, O88506, O95747, P28547, P38990, P83098, P9WI62, P9WI63, Q11112, Q3UUJ4, Q4R6X5, Q4U925, Q54Q69, Q551H4, Q5E9J9, Q5R495, Q5RBJ6, Q5ZK47, Q6P9R2, Q7RTN6, Q7TNZ6, Q7TYY6, Q863I2, Q8BYG9, Q8G4G1, Q8K4T3, Q8NE28, Q95QC4, Q9C0K7, Q9ES74, Q9ESG9, Q9UEW8, Q9Z1W9, B6F107
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
125 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 102 |
| Likely benign | 8 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3920 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:133379030:T:A | acceptor_gain | 1.0000 |
| 9:133379033:TAGGT:T | acceptor_loss | 1.0000 |
| 9:133379034:A:T | acceptor_loss | 1.0000 |
| 9:133379119:GCAG:G | donor_gain | 1.0000 |
| 9:133379122:GGTA:G | donor_loss | 1.0000 |
| 9:133379123:G:GC | donor_loss | 1.0000 |
| 9:133379124:T:A | donor_loss | 1.0000 |
| 9:133390793:G:GT | donor_gain | 1.0000 |
| 9:133390794:A:T | donor_gain | 1.0000 |
| 9:133394406:GGAT:G | donor_gain | 1.0000 |
| 9:133394407:GATG:G | donor_gain | 1.0000 |
| 9:133394410:G:GG | donor_gain | 1.0000 |
| 9:133395598:A:AG | acceptor_gain | 1.0000 |
| 9:133395598:AG:A | acceptor_gain | 1.0000 |
| 9:133395599:G:GA | acceptor_loss | 1.0000 |
| 9:133395599:G:GG | acceptor_gain | 1.0000 |
| 9:133395599:GG:G | acceptor_gain | 1.0000 |
| 9:133395599:GGGC:G | acceptor_gain | 1.0000 |
| 9:133395710:G:GT | donor_gain | 1.0000 |
| 9:133395759:A:G | donor_gain | 1.0000 |
| 9:133395759:ATAAA:A | donor_gain | 1.0000 |
| 9:133395760:TAAA:T | donor_gain | 1.0000 |
| 9:133395761:AAAG:A | donor_loss | 1.0000 |
| 9:133395762:AAGT:A | donor_loss | 1.0000 |
| 9:133395763:AG:A | donor_loss | 1.0000 |
| 9:133395764:G:GG | donor_gain | 1.0000 |
| 9:133395764:GTG:G | donor_loss | 1.0000 |
| 9:133395765:T:A | donor_loss | 1.0000 |
| 9:133397162:AG:A | acceptor_gain | 1.0000 |
| 9:133397163:GG:G | acceptor_gain | 1.0000 |
AlphaMissense
4466 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:133379119:G:C | K57N | 0.993 |
| 9:133379119:G:T | K57N | 0.993 |
| 9:133394359:T:A | W218R | 0.992 |
| 9:133394359:T:C | W218R | 0.992 |
| 9:133394308:T:A | W201R | 0.991 |
| 9:133394308:T:C | W201R | 0.991 |
| 9:133405317:T:C | F647L | 0.987 |
| 9:133405319:C:A | F647L | 0.987 |
| 9:133405319:C:G | F647L | 0.987 |
| 9:133385671:T:C | F92L | 0.984 |
| 9:133385673:C:A | F92L | 0.984 |
| 9:133385673:C:G | F92L | 0.984 |
| 9:133390690:A:C | K159N | 0.982 |
| 9:133390690:A:T | K159N | 0.982 |
| 9:133390686:T:A | L158H | 0.980 |
| 9:133394361:G:C | W218C | 0.980 |
| 9:133394361:G:T | W218C | 0.980 |
| 9:133394353:G:C | D216H | 0.979 |
| 9:133394368:G:C | G221R | 0.979 |
| 9:133389572:T:C | L148P | 0.978 |
| 9:133390699:C:A | N162K | 0.978 |
| 9:133390699:C:G | N162K | 0.978 |
| 9:133394369:G:A | G221D | 0.978 |
| 9:133390742:A:C | S177R | 0.976 |
| 9:133390744:T:A | S177R | 0.976 |
| 9:133390744:T:G | S177R | 0.976 |
| 9:133394354:A:C | D216A | 0.975 |
| 9:133395751:G:C | R285P | 0.975 |
| 9:133389592:C:G | H155D | 0.974 |
| 9:133394338:T:C | F211L | 0.974 |
dbSNP variants (sampled 300 via entrez): RS1000027809 (9:133375527 G>A,C), RS1000094615 (9:133374372 G>C), RS1000447742 (9:133398517 G>A), RS1000546467 (9:133399961 C>T), RS1000613058 (9:133398808 T>C), RS1000899095 (9:133388912 C>T), RS1000910768 (9:133389299 T>C), RS1000957074 (9:133380936 A>G), RS1001090397 (9:133395330 G>A), RS1001269497 (9:133380595 G>T), RS1001337394 (9:133375319 G>A), RS1001534794 (9:133391285 T>C), RS1001713237 (9:133403913 T>G), RS1001788613 (9:133375434 G>A), RS1001942951 (9:133378843 G>A)
Disease associations
OMIM: gene MIM:618530 | disease phenotypes:
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| polydactyly | Limited | Autosomal dominant |
Mondo (1): polydactyly (MONDO:0021003)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001793_1 | Coagulation factor levels | 4.000000e-34 |
| GCST001793_4 | Coagulation factor levels | 1.000000e-128 |
| GCST010083_318 | Hemoglobin levels | 2.000000e-47 |
| GCST010725_19 | Malaria | 9.000000e-11 |
| GCST010725_31 | Malaria | 9.000000e-21 |
| GCST010725_98 | Malaria | 1.000000e-19 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004509 | hemoglobin measurement |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D017689 | Polydactyly | C05.660.585.600; C16.131.621.585.600 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: enzyme — Other-unique family
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| afimoxifene | decreases response to substance | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| perfluorohexanesulfonic acid | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Testosterone | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
2 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT00001404 | Not specified | COMPLETED | Phenotype and Etiology of Pallister-Hall Syndrome |
| NCT06239064 | Not specified | ACTIVE_NOT_RECRUITING | Early Genetic Identification of Obesity |
Related Atlas pages
- Associated diseases: polydactyly
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): polydactyly